Could Acadia use the p1 results from Neuren for Fragike X though - it would make sense from a safety perspective, but if that was the case then Neuren wouldn’t need to run any additional p1 trials fir the 3 additional indications they are running now, unless the dosage is different, but I don’t think it is…
- Forums
- ASX - By Stock
- Share Price
Could Acadia use the p1 results from Neuren for Fragike X though...
-
- There are more pages in this discussion • 837 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.51 |
Change
-0.480(2.40%) |
Mkt cap ! $2.505B |
Open | High | Low | Value | Volume |
$20.10 | $20.10 | $19.40 | $1.681M | 85.57K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 357 | $19.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.53 | 127 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 239 | 19.520 |
3 | 193 | 19.510 |
4 | 1799 | 19.500 |
5 | 399 | 19.490 |
4 | 271 | 19.480 |
Price($) | Vol. | No. |
---|---|---|
19.530 | 37 | 2 |
19.540 | 693 | 12 |
19.550 | 366 | 5 |
19.560 | 297 | 5 |
19.570 | 294 | 3 |
Last trade - 11.22am 09/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |